Drug Topics June 25, 2025
Researchers presented an abstract describing current racial disparities in CGM access and wear time to better inform quality improvement efforts.
Racial disparities in hemoglobin A1c (HbA1c) and continuous glucose monitor (CGM) use persist as Black and Hispanic youth report poorer outcomes when compared with White teens.
Aside from disparities in HbA1c and overall CGM use, researchers uncovered inequities in CGM wear time and access, according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025.1
“Inequities in CGM use contribute to health disparities among teens with type 1 diabetes (T1D),” wrote authors of the abstract. “Recent changes in insurance coverage and standards of care may have reduced systemic barriers to...
Today's Sponsors
Today's Sponsor